HITS

About:

HITS is a biotech company that creates digital solutions to accelerate drug development and introduce a new drug discovery paradigm.

Website: https://hits.ai

Top Investors: Korea Investment Partners, Kiwoom Investment, Company K Partners, Capstone Partners, STIC Ventures

Description:

HITS is a biotech company that creates digital solutions to accelerate drug development and introduce a new drug discovery paradigm. The company creates a cloud-based drug development platform that connects AI models with docking and molecular dynamics.

Total Funding Amount:

5.5B KRW

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2020-01-01

Contact Email:

contact(AT)hits.ai

Founders:

Jaechang Lim, Woo Youn Kim

Number of Employees:

11-50

Last Funding Date:

2022-02-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai